↓ Skip to main content

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

Overview of attention for article published in Radiation Oncology, September 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
Published in
Radiation Oncology, September 2017
DOI 10.1186/s13014-017-0893-x
Pubmed ID
Authors

Katrien De Wolf, Sylvie Rottey, Karim Vermaelen, Karel Decaestecker, Nora Sundahl, Lizzy De Lobel, Els Goetghebeur, Gert De Meerleer, Nicolaas Lumen, Valérie Fonteyne, Daan De Maeseneer, Piet Ost

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 19%
Other 5 12%
Student > Ph. D. Student 5 12%
Student > Doctoral Student 4 9%
Researcher 3 7%
Other 6 14%
Unknown 12 28%
Readers by discipline Count As %
Medicine and Dentistry 18 42%
Nursing and Health Professions 4 9%
Computer Science 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Agricultural and Biological Sciences 1 2%
Other 2 5%
Unknown 14 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2019.
All research outputs
#5,841,066
of 23,133,982 outputs
Outputs from Radiation Oncology
#239
of 2,081 outputs
Outputs of similar age
#91,965
of 318,891 outputs
Outputs of similar age from Radiation Oncology
#7
of 34 outputs
Altmetric has tracked 23,133,982 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 2,081 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,891 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.